SEARCH

SEARCH BY CITATION

REFERENCES

  • Ammit, AJ, & O'Neill, C (1997). Studies of the nature of the binding by albumin of platelet-activating factor released from cells. J Biol Chem 272, 1877218778.
  • Archer, CB, MacDonald, DM, Morley, J, Page, CP, Paul, W & Sanjar, S (1985). Effects of serum albumin, indomethacin and histamine H1-antagonists on PAF-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol 85, 109113.
  • Ayala, A, & Chaudry, IH (1996). Platelet activating factor and its role in trauma shock and sepsis. New Horizons 4, 265275.
  • Benveniste, J, (1990). The history and some prospects of PAF-acether (PAF or AGEDC). In Platelet-activating Factor in Endotoxin and Immune Diseases, ed. Handley, DA, Saunders, RN, Houlihan, WJ & Tomesh, JC, pp. 314. Marcel Dekker, New York .
  • Bessin, P, Bonnet, J, Apffel, P, Soulard, C, Desgrou, L, Pelassi, I & Benveniste, J (1983). Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur J Pharmacol 86, 403413.
  • Beyer, AJ, Smalley, DM, Shyr, Y-M, Wood, JG & Cheung, LY (1998). PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. Am J Physiol Gastrointest Liver Physiol 275, G467472.
  • Borman, RA, Jewell, R & Hillier, K (1998). Investigation of the effect of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br J Pharmacol 123, 231236.
  • Braquet, P, Touqui, L, Shen, TY & Vargaftig, BB (1987). Perspectives in platelet-activating factor research. Pharmacol Rev 39, 97145.
  • Bratton, DL, Harris, RA, Clay, KL & Henson, PM (1988). Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. Biochim Biophys Acta 941, 7682.
  • Brus, R, Krzeminski, T, Juraszczyk, Z, Kurcok, A, Felinska, W & Kozik, W (1986). Central effects of leukotriene C4 and D4 in rats and mice. Biomed Biochim Acta 45, 11531158.
  • Camussi, G, Mariano, F, Biancone, L, De Martino, A, Bussolati, B, Montrucchio, G & Tobias, PS (1995). Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 155, 316324.
  • Chang, SW, Feddersen, CO, Henson, PM & Voelkel, NF (1987). Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 79, 14981509.
  • Clay, KL, Johnson, C & Henson, P (1990). Binding of platelet activating factor to albumin. Biochim Biophys Acta 1046, 309314.
  • Clemmer, TP, Fisher, CJ, Jr., Bone, RC, Slotman, GJ, Metz, CA & Thomas, FO (1992). Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 20, 13951401.
  • Doebber, TW, Wu, MS, Robbins, JC, Choy, BM, Chang, MN & Shen, TY (1985). Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun 127, 799808.
  • Eguchi, N, Hayashi, H, Urade, Y, Ito, S & Hayaishi, O (1988). Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats. J Pharmacol Exp Ther 247, 671679.
  • Ephgrave, K, Kremer, T, Broadhurst, K & Cullen, J (1997). The role of platelet-activating factor in conscious, normotensive endotoxemia. J Surg Res 68, 170174.
  • Feuerstein, G, & Hallenbeck, JM (1987). Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol 27, 301313.
  • Gerkens, JF, (1990). Reproducible vasodilation by platelet-activating factor in blood and Krebs-perfused rat kidneys is albumin-dependent. Eur J Pharmacol 177, 119126.
  • Giral, M, Balsa, D, Ferrando, R, Merlos, M, Garcia-Rafanell J & Forn J (1996). Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock. Br J Pharmacol 118, 12231231.
  • Han, S-J, Choi, J-H, Ko, H-M, Yang, H-W, Choi, I-W, Lee, H-K, Lee, O-H & Im, S-Y (1999). Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 29, 13341341.
  • Han, S-J, Ko, H-M, Choi, J-H, Seo, KH, Lee, H-S, Choi, E-K, Choi, I-W, Lee, H-K & Im, S-Y (2002). Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-κ B (NF-κB). J Biol Chem 277, 4471544721.
  • Heirwegh, KP, (1984). Effects of binding of amphipathic compounds to carrier proteins on their enzymatic biotransformation by membrane-bound enzymes. Biochem Soc Trans 12, 1113.
  • Huang, L, Tan, X, Crawford, SE & Hsueh, W (1994). Platelet-activating factor and endotoxin induce tumor necrosis factor gene expression in rat intestine and liver. Immunology 83, 6569.
  • Ishii, S, Nagase, T, Tashiro, F, Ikuta, K, Sato, S, Waga, I, Kume, K, Miyazaki, J & Shimizu, T (1997). Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16, 133142.
  • Ivanov, AI, Pero, RS, Scheck, AC & Romanovsky, AA (2002). Prostaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation. Am J Physiol Regul Integr Comp Physiol 283, R11041117.
  • Jaranowska, A, Bussolino, F, Sogos, V, Arese, M, Lauro, GM & Gremo, F (1995). Platelet-activating factor production by human fetal microglia. Effect of lipopolysaccharides and tumor necrosis factor-α. Mol Chem Neuropathol 24, 95106.
  • Kramp, W, Pieroni, G, Pinckard, RN & Hanahan, DJ (1984). Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs. Chem Phys Lipids 35, 4962.
  • Kuijpers, TW, Van Der Poll T & Levi M (1994). Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzee. J Immunol 152, 24382446.
  • Kulikov, VI, & Bergel'son, LD (1984). Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes. Biokhimiia 49, 13101315 (in Russian).
  • Libert, C, Van Molle W, Brouckaert P & Fiers W (1996). α1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 157, 51265129.
  • Million, M, Fioramonti, J, Zajac J-M & Bueno L (1997). Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor. Eur J Pharmacol 334, 6773.
  • Milton, AS, (1998). Prostaglandins and fever. Prog Brain Res 115, 129139.
  • Montrucchio, G, Alloatti, G & Camussi, G (2000). Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80, 16691699.
  • Prescott, SM, Zimmerman, GA, Stafforini, DM & McIntyre, TM (2000). Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69, 419445.
  • Qu, X-W, Rozenfeld, RA, Huang, W, Crawford, SE, Gonzalez-Crussi, F & Hsueh, W (1998). Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J Physiol 512, 227234.
  • Rabinovici, R, Abdullah, F, Mathiak, G & Feuerstein, G (1999). Platelet-activating factor in sepsis: an update. In Endotoxin in Health and Disease, ed. Brade, H, Opal, SM, Vogel, SN & Morrison, DC, pp. 561579. Marcel Dekker, New York .
  • Romanovsky, AA, (2000). Thermoregulatory manifestations of systemic inflammation: lessons from vagotomy. Auton Neurosci 85, 3948.
  • Romanovsky, AA, Ivanov, AI, Karman, EK (1999). Blood-borne, albumin-bound prostaglandin E2 may be involved in fever. Am J Physiol Regul Integr Comp Physiol 276, R18401844.
  • Romanovsky, AA, Ivanov, AI & Shimansky, YP (2002). Selected contribution: Ambient temperature for experiments in rats: A new method for determining the zone of thermal neutrality. J Appl Physiol 92, 26672679.
  • Romanovsky, AA, Kulchitsky, VA, Simons, CT & Sugimoto, N (1998). Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Physiol Regul Integr Comp Physiol 275, R332338.
  • Siren AL, Heldman E, Doron D, Lysko PG, Yue TL, Liu Y, Feuerstein G & Hallenbeck JM (1992). Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke 23, 16431650.
  • Sun, XM, Hsueh, W & Torre-Amione, G (1990). Effects of in vivo ‘priming’ on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. Am J Pathol 136, 949956.
  • Syrbu, SI, Waterman, WH, Molski, TF, Nagarkatti, D, Hajjar J-J & Sha'afi RI (1999). Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. J Immunol 162, 23342340.
  • Székely, M & Szelényi, Z (1979). Endotoxin fever in the rat. Acta Physiol Acad Sci Hung 53, 265277.
  • Terashita, Z-I, Imura, Y, Nishikawa, K & Sumida, S (1985). Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol 109, 257261.
  • Thivierge M & Rola-Pleszynski M (1995). Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages. J Immunol 154, 65936599.
  • Ueno, R, Narumiya, S, Ogorochi, T, Nakayama, T, Ishikawa, Y & Hayaishi, O (1982). Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc Natl Acad Sci USA 79, 60936097.